DRUG-MONOCLONAL ANTIBODY CONJUGATES FOR CANCER-THERAPY

被引：0
|
作者：
REISFELD, RA [1 ]
VARKI, NM [1 ]
WALKER, LE [1 ]
机构：
[1] SCRIPPS CLIN & RES FDN,DEPT IMMUNOL,LA JOLLA,CA 92037
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：410 / 410
页数：1
相关论文
共 50 条
  • [21] Monoclonal antibody-drug conjugates
    Hamann, PR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (09) : 1087 - 1103
  • [22] Development of potent monoclonal antibody auristatin conjugates for cancer therapy
    Svetlana O Doronina
    Brian E Toki
    Michael Y Torgov
    Brian A Mendelsohn
    Charles G Cerveny
    Dana F Chace
    Ron L DeBlanc
    R Patrick Gearing
    Tim D Bovee
    Clay B Siegall
    Joseph A Francisco
    Alan F Wahl
    Damon L Meyer
    Peter D Senter
    Nature Biotechnology, 2003, 21 : 778 - 784
  • [23] Development of potent monoclonal antibody auristatin conjugates for cancer therapy
    Doronina, SO
    Toki, BE
    Torgov, MY
    Mendelsohn, BA
    Cerveny, CG
    Chace, DF
    DeBlanc, RL
    Gearing, RP
    Bovee, TD
    Siegall, CB
    Francisco, JA
    Wahl, AF
    Meyer, DL
    Senter, PD
    NATURE BIOTECHNOLOGY, 2003, 21 (07) : 778 - 784
  • [24] Recent advances in antibody drug conjugates for cancer therapy
    Meyer, DL
    Senter, PD
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38, 2003, 38 : 229 - 237
  • [25] Novel antibody drug conjugates for pancreatic cancer therapy
    Huang, Jing
    Guo, Peng
    Moses, Marsha
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [26] Potential of antibody–drug conjugates (ADCs) for cancer therapy
    Hany E. Marei
    Carlo Cenciarelli
    Anwarul Hasan
    Cancer Cell International, 22
  • [27] Antibody-Drug Conjugates for Targeted Cancer Therapy
    Goldmacher, Victor S.
    Chittenden, Thomas
    Chari, Ravi V. J.
    Kovtun, Yelena V.
    Lambert, John M.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 349 - 366
  • [28] Unlocking the potential of antibody–drug conjugates for cancer therapy
    Joshua Z. Drago
    Shanu Modi
    Sarat Chandarlapaty
    Nature Reviews Clinical Oncology, 2021, 18 : 327 - 344
  • [29] MONOCLONAL-ANTIBODIES IN CANCER-THERAPY
    RIETHMULLER, G
    SCHNEIDERGADICKE, E
    JOHNSON, JP
    CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (05) : 732 - 739
  • [30] SPECIFIC ACTIVATION OF GLUCURONIDE PRODRUGS BY ANTIBODY-TARGETED ENZYME CONJUGATES FOR CANCER-THERAPY
    WANG, SM
    CHERN, JW
    YEH, MY
    NG, YC
    TUNG, E
    ROFFLER, SR
    CANCER RESEARCH, 1992, 52 (16) : 4484 - 4491
12345